HOME >> MEDICINE >> NEWS
Effective government/industry collaboration bolsters flu vaccine supply

When faced with an urgent public health need, the federal government, vaccine manufacturers and university-based researchers can work together quickly and effectively to come up with solutions, as demonstrated in the successful clinical trial of the influenza vaccine Fluarix. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), working closely with the Food and Drug Administration (FDA), sponsored the clinical trial that demonstrated the vaccine's safety and ability to generate an immune response and ultimately led to its expedited approval by FDA in August 2005. Fluarix is the first vaccine to receive FDA approval under the agency's accelerated approval regulations.

Details of the Fluarix clinical study are discussed in the November/December 2005 issue of Human Vaccines, available online December 22.

Clinical testing of the seasonal influenza vaccine Fluarix began in December 2004 as an effort to augment the future U.S. flu vaccine supply, which was experiencing an unexpected, significant shortage. Fluarix, which is manufactured by GlaxoSmithKline Biologicals of Rixensart, Belgium, had been approved in 1998 for use in other countries but had never been tested or licensed for use in the United States.

The vaccine was evaluated in a clinical trial involving nearly 1,000 healthy adults at four sites nationwide. Clinical evaluation of the candidate vaccine was performed under an FDA-reviewed "investigational new drug" application, in which potential study volunteers are fully informed about potential risks and benefits and must provide their informed consent before receiving the investigational product. The clinical trial was rapidly initiated and reached capacity enrollment within five days of its launch in December 2004.

"The Fluarix study is an excellent example of what government and industry can accomplish in a short timeframe when faced with a serious public health nee
'"/>

Contact: Kathy Stover
kstover@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
22-Dec-2005


Page: 1 2 3

Related medicine news :

1. Effectiveness of first renin inhibitor drug for treating hypertension is limited
2. Effectiveness of over-the-counter decongestant questioned in new study
3. Effective medical response reduced deaths of critically injured after London bombings
4. Effective HIV control may depend on viral protein targeted by immune cells
5. Effective treatments for panic disorder not reaching patients
6. Effective alcohol dependence treatments defined
7. Effective treatment of a mothers depression reduces risk of psychiatric disorders in her children
8. Effective hospital patient handoffs require better training for physicians
9. Acrux and Oreganon further expand their collaboration
10. Asia-European collaboration addresses water management in Indonesia
11. Penn leads $98 million translational medicine collaboration

Post Your Comments:
(Date:2/27/2015)... San Diego, CA (PRWEB) February 27, 2015 ... Industries’ Vortex-Genie® 2 , price is only valid ... caters to lab technicians looking for a vortex mixer ... , Scientific Industries was founded in 1954 and is ... Vortex-Genie® laboratory mixers & shakers, as well as other ...
(Date:2/27/2015)... Evans, GA (PRWEB) February 27, 2015 In honor ... Center for Primary Care (CPC) South office, is offering tips on ... leading cause of death, but that doesn't mean people have to ... to change some risk factors — such as family history, sex ... to take. , Dr. Scott has six helpful tips to ...
(Date:2/27/2015)... NY (PRWEB) February 27, 2015 In ... to the community by providing free dental care from ... has partnered with Dentistry from the Heart, and ... 11, 2015. The first 50 patients who are in ... they can’t afford, will have access to high­quality service ...
(Date:2/27/2015)... Undocumented farmworkers are half as ... Medicaid, the federal health insurance program available to ... study from UC Davis Health System. The research ... use of Medicaid, which provides coverage for prenatal, ... was having children. , “Undocumented agricultural workers ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The V ... cancer research funding organizations, is excited to announce numerous ... to participate and many long-standing partnerships highlight The V ... focus on expanding ways for all to get involved. ... to cutting-edge cancer research, The V Foundation has funded ...
Breaking Medicine News(10 mins):Health News:Pipette.com Announces Limited Time Offer of 24% Off List Price on the Vortex-Genie 2 2Health News:Center for Primary Care Celebrates American Heart Month 2Health News:Center for Primary Care Celebrates American Heart Month 3Health News:Center for Primary Care Celebrates American Heart Month 4Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 2Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 3Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 3
(Date:2/26/2015)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced that ... financial results after the market closes on Thursday, March ... will host a conference call with the investment community at ... 5, 2015 to discuss the results of the quarter ... the live conference call via telephone by dialing (877) 407-0784 ...
(Date:2/26/2015)... N.Y. , Feb. 26, 2015 Every ... more research to fight heart disease.  Nevertheless, year after ... on ElectroCardioGrams (EKG) as the first test to determine ... they have chest pain or not, even though that ... occurs despite the fact that doctors know, (while most ...
(Date:2/26/2015)... MILFORD, Mass. , Feb. 26, 2015 /PRNewswire/ ... developing novel therapeutics for the treatment of Hepatitis ... announced the closing of a $22 million financing. ... of SB 9200, a novel, broad spectrum antiviral ... molecule nucleic acid hybrid (SMNH) chemistry platform, into ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2National Heart Health Month In February 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2
Cached News: